Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Novo Nordisk Looks To Increase Its Global GLP-1 Lead
Strategy Includes Cementing Dominance In Obesity As Sales Growth Flattened In Q2
Aug 06 2020
•
By
Sten Stovall
Novo Nordisk used its Q2 update to outline product transitions • Source: Shutterstock
More from Earnings
More from Business